Abstract-Anglotensm (Ang) II increases substance P (SP) emux from perfused slices of medulla oblongata, and a peptlde antagonist of SP, [Leu",$CH,NHlO-1 l]SP, blocks the acute hypotenslon and bradycardla caused by Ang II injected mto the nucleus tractus sohtaru (nTS) of Harlan Sprague-Dawley (SD) rats. We investigated whether the same relatlonshlps exist m (mRen2)27 remn transgemc (TG) rats, which have chronic elevations of medullary tissue Ang II levels Ang II increased SP efflux (48% above control, P<O 01) from slices of medulla prepared from 8-to 12-week old male TG rats Iqectlons of Ang II (250 fmol m 30 nL) mto the nTS of chloralose-urethane anesthetized TG rats produced a slgmficant increase m pressure of 722 mm Hg before a 13+3 mm Hg fall m pressure Ang II mduced slmllar depressor responses m Hannover SD rats but no mcrease m prenure After nTS uqectlon of the NKl-selective SP antagomst CP-96,345 (30 pmol m 60 nL), Ang II-induced hypotenslon wa$ blocked m both groups, as was the pressor component m hypertensive rats Hypotenslve and bradycardlc effects of glutamate (0 6 nmol m 30 nL) injected mto the nTS were not altered by 345 In vitro receptor autoradlography showed that the SP antagomst (10 or 100 FM) did not compete for '?-Ang II bmdmg m the dorsal medulla, a result suggesting that it did not Interact directly with Ang II receptors Thus, the nTS cardiovascular effects of Ang II are mediated by SP m both normotenslve rats and a model of hypertension with altered endogenous levels of Ang II These findings link Ang II-induced effects on SP release from brain slices of the medulla oblongata to acute cardiovascular actions of the peptlde through an NKl receptor (Hypertension. 1998;31[part 2]:473-479.) Key Words: anglotensm II H substance P n NKl receptor n CP-96,345 n dorsal medulla n (mRen2)27 remn transgemc rat n nucleus tractus sohtaru n blood pressure 0 ur previous work has focused on the cell groups and transmitters involved in the reflex regulation of the cardiovascular system, specifically, the nucleus tractus sohtaru (nTS) and dorsal motor nucleus of the vagus (dmnX) These nuclei receive baroreceptor Input from the vagus and glossopharyngeal nerves and contain substance P-lmmunoreactlvlty is2 Several years ago, when first mapping the anatomical dlstnbutlon of anglotensm II receptors m the dorsal medulla oblongata, nodose ganglion, and vagus nerve,3-7 we observed that the dlstnbutlon of substance P lmmunoreactlvlty had a stnkmg slmllarlty to the dlstnbutlon of the angotensm II bmdmg sites 6
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As a result of these observations, we investigated the potential functional mteractlons between these two peptlde systems and showed that anglotensm II increases substance P eflux from bram slices x-10 Moreover, both peptldes injected into the nTS cause hypotenslon/bradycardla at low doses and pressor/tachycar&c actlons at high doses 11-13 A peptlde analogue substance P antagonist, [Leu",CH2NH10-1 I] substance P, blocks the hypotenslve/bradycardlc actions of anglotensm II m the nTS of normotenslve Sprague-Dawley (SD) rats I4 This latter finding firmly linked the anatomical observations to a functional relationship between the two peptlde systems with respect to cardiovascular function To investigate whether these relatlonshlps between angotensm II and substance P are altered m hypertension, we used the (mRen2)27 renm transgemc (TG) rat, a model for overexpression of tissue anglotensm peptldes This model was developed by Mullms et ali5 and 1s characterized by extremely high tissue levels of angotensm II m the medulla oblongata and moderately elevated plasma levels of the peptlde I6 Using this model, we observed that the Increases m artenal pressure m response to mtracerebroventncular qectlons of angotensln II were reduced.17 Vasopressm release from the paraventncular nucleus was also markedly attenuated m response to angotensm II 17 In addition, substance P release from hypothalatmc slices was blunted m response to angotensm peptldes In TG compared with normotenslve SD rats."' These reduced responses are also seen m cell cultures denved from the TG rat 18*1y Thus, we formulated the hypothesis that the chronic overexpresslon of angotensm II results m downregulatlon of the responses to exogenously admuustered anglotensms
The objectwe of the present work was to determine whether m the TG rat, the responses to exogenous angotensm II were altered m the dorsal medulla in terms of either magnitude of the response or dependence on substance P In addltlon, we used a NKl-selective tachykmm receptor antag- 
Microinjection Studies
After mducclon of anesthesia m 9 TG and 11 SD rats by mtrapentoneal mJecuon (35 mg chloralose, 750 mg urethane/kg), catheters were Inserted mto the femoral artery and vem Rats were placed m a stereotaxlc frame with the head flexed downward at 45O and qurglcally opened to expose the dorsal medulla by mclsmg the atlanto-occlpltal membrane
The pipette was placed mto the nTS (0 5 mm rostra1 and 0 5 mm lateral to calamus Fcnptonus, 1 e , the caudal tip of the area postrema, and 0 5 to 0 6 mm below the dorsal surface) I' I3 Arterial pressure and heart rate were acqmred via strain gauge transducer Angiotensin II Receptor Autoradiography Sections of medulla oblongata (14 pm) were prepared from frozen brains obtained from two additional SD rats Sections were mcubated m 0 4 nmol/L ?-angotensm II m a phosphate buffer alone or m the presence of 2 pmol/L angiotensm II to determine specific bmdmg 1 '4 AdJacent sections were mcubated wtth IO or 100 pmol/L of the NKl-selective substance P antagonist After rmsmg and drying accorclmg to our pubhshed protocols,3 shdes were placed with x-ray film m cassettes for 5 days at room temperature, and developed films were analyzed by densltometry At least two sections (both right and left sides) from each rat were analyzed and reported as one value for each of the above concbtions (total bmdmg, nonspecific, 10 and 100 pmol/L CP-96,345)
Analysis of Data
Values are reported as means-+ 1 SEM Unpaired Student's t-tests were used to compare arterial pressure, heart rate, body weight, and basal release between TG and SD rats Paired comparisons were used among treatment groups in a given rat stram (angotensm Ii or glutamate before versus after the NKI receptor antagomst) For the release studies, responses dunng the sttmulus penod were expressed as percent of basal If basal values and values from the subsequent period were below the detection hmtt, the data were excluded from, the stimulus period analysis, as the percent change from basal could not be deterrnmed Logarlthn-nc transformauon of the data was performed to a&eve homogeneity of variance for the release stuches Excel (Mlcrosoft Office 95) and InStat and Pnsm (GraphPad) software were used for these analyses P<O 05 was taken to m&ate a slgmt'icant difference among means
Results

Comparison of Initial Hemodynamic Values in TG and SD Rats
Systohc blood pressure and body weight for TG and SD animals used m the substance P release or micromJection Systolic blood pressure by tall cuff and body weight were determined In the week preceding the experiment Basal substance P values indicate the amount of immunoreachve substance P detected in the 6-minute collechon period precedrng the sbmulus period Values are expressed per Qram of wet tissue weight (pg/g) or per millrliter of perfusate collected (pg/mL) Experimental period substance P release IS the amount of substance P detected during the second 6-minute collection period expressed as the percent of basal release (krst 6-minute collecbon period) The control treatment consrsted of contmued perfusion with the Krebs buffer without AnQ II (2 PM) dUrlnQ the second collection period Values are mean?SEM Numbers in parentheses mdrcate number of rats **P<O 01 compared wtth control treatment (buffer only) *"*P<O 01 when TG rats were compared with SD rats experiments are shown m Tables 1 and 2 Systolic pressure measured by tall cuff m conscious rats averaged slgmficantly higher m TG rats compared with the normotenslve SD controls for both groups of studies The values obtained by this method are comparable to previous values obtained m other studies either by tall CL@" or mdwellmg catheter m conscious rats.*" Systolic pressure remained elevated with respect to the SD rats m the hypertensive rats under the chloralose-urethane anesthesia, but mean arterial pressure was equivalent m nor- As indicated above, baseline mean arterial pressure and heart rate under anesthesia in these experiments did not differ between the hypertensive and normotensive rats for all rats studied (Table 2) or for any individual group (Figures 1 and 2) . The fall in blood pressure in response to angiotensin II was also similar in the two groups of rats. In both TG (n=7) and SD (n=9) rats, angiotensin II decreased mean arterial pressure approximately -13 mm Hg (Figs 1 and 2 ) after a prior aCSF injection of 60 nL. In only the TG rats was the depressor response preceded by a significant increase in pressure of 724 mm Hg (X0.05 versus zero). When the angiotensin II injections were given approximately 10 min after 60 nL of 30 pm01 CP-96,345, the angiotensin II depressor responses were blocked (X0.05;
Figures lA, lB, and 2). The angiotensin II-induced pressor effect was reduced by approximately 50% and no longer represented a significant increase in pressure (424 mm Hg, not significantly different from zero). In a limited number of SI) rats (n=6), we injected angiotensin II into the nTS 40 to 60 minutes after the NKl antagonist. There was only partial recovery of the depressor response at this time (-622 mm Hg). This is similar to what we observed with the modified peptide antagonist in previous studies"' in which the response returned to control values only after 90 minutes. We did not attempt to wait for the response to return to control in the present experiments with the presumably longer acting nonpeptide antagonist.
There were no significant effects on arterial pressure or heart rate with the CP-96,345 injections alone in either group of rats (SD: -322 mm Hg and -12?9 beats/min; TG: -421 mm Hg and -354 beats/mill; P>O.O5, compared with vehicle). In addition, similar nonsignificant falls in heart rate occurred after angiotensin II injections in either SD or TG rats before (-7 t 6 beats/min versus -6t 2 beats/min, respectively) or after (-223 beats/min versus -4t4 beats/min, respectively) the NKl receptor antagonist injections.
Assessment of the Specificity of the Effect of CP-96,345
In both TG and SD rats, glutamate (0.6 nmol) produced the typical falls in heart rate and blood pressure seen m previous studies.'Q" The NKI receptor antagonist did not block the hypotensive response to glutamate mJectlons m SD (-2026 mmHg before versus -20+4 mmHg after CP-96,345; n=5) or TG rats (-18t9 mm Hg before versus -2127 mm Hg after CP-96,345; n=5). There waq also no effect of the antagonist on the fall in heart rate with glutamate m these same SD (-41+12 beats/mm before versus -40217 beats/min after CP-96,345) or TG rats (-242 15 beats/min before versus -342 14 beats/min after CP-96,345). There was no significant difference between SD and TG rats in terms of the magnitude of the hypotensive and bradycardlc responses to glutamate (comparison of values mdicated as "before" CP-96,345 111 the above; n=5, each; P>O.O5).
The NKl antagonist CP-96,345 was also evaluated for its ability to interact directly with Ang II receptors in the dorsal medulla of SD rats. There are reported mteractlons between losartan, an angiotensm II AT, receptor blocker, and NK3 receptors in the hypothalamus. 27,28 The nonpeptlde substance P antagonist CP-96,345 did not compete for '*'I-angiotensm II binding m sections of medulla oblongata from two SD rats. Angiotensin II binding was unaltered by the CP-96,345 at either 10 PM (626% competition) or 100 PM (OtO% competition).
Discussion
The present study has four major findings. First, we showed that basal and angiotensm II-stimulated substance P releate was similar m medullary shces from TG and SD rats. Second, the depressor effect of angiotensm II m the nTS of TG rats waq similar to that seen m SD rat$, and an NKl-selective substance P antagonist blocked the cardlovaqcular effects in both group5 of animals. Third, there was an initial pressor component to the responses in the TG rat, consistent with actions seen m response to higher doses of angiotensm II. Finally, under chloralose-urethane anesthesia, the mean arterial pressure was normalized m the TG rats Gwen that this anesthetic agent maintains pressure at conscious levels in normotensive rats, one interpretation 1s that the level of pressure m the TG rat 1s largely supported by centrally mediated sympathetic outflow This interpretation 1s supported by the fact that urethane anesthesia 1s known to mhlblt an overactive sympathetic nervous system at both central and penpheral sites of action 29 In addition, urethane anesthesia normally activates the renal remn-angotensm system to mamtam pressure 2y Since the TG rat has suppressed renal remn, the failure to activate this system could also contribute to the exaggerated fall m pressure that 1s seen m these animals
We recently reportedt4 that the acute depressor and bradycardlc effects of angotensm II m Harlan Sprague-Dawley rats were blocked by pnor admmlstratlon of a peptlde substance P antagonist ?" This confirmed a functional relatlonshlp between these transmitter systems that was postulated on the basis of anatomlc,3-h 31 electrophyslologc,8*32J3
and pharmacolog+:) data. Importantly, the previous findings revealed a mechanism to account for the similar cardiovascular effects of angotensm II and substance P m this brain regon ",'* Moreover, the pressor component of the response m TG rats 1s similar to what 1s seen with higher (pmol as opposed to fmol range) doses of either anglotensm II or substance P,11-13 and the CP-96,345 antagonist blocked both the pressor and depressor responses The current studies also extend the previous findings by demonstrating that substance P acts at an NKl receptor Th:s 1s consistent with data mdlcatmg that substance P 1s the major tachykmm present m the dorsal medulla'* and that the majority of the peptlde's actions are medlated by the NKl receptor subtype 74
It 1s unlikely that the substance P mechanisms contnbutmg to the acute depressor and bradycardlc or even the pressor effects of angotensm II m the dorsal medulla are the same as those medlatmg the baroreceptor reflex actions of angotensm II m this bram area This IS because substance P reportedly facilitates the baroreceptor reflex, whereas angotensm II mhlblts it 35-37 However, m the present study, the substance P antagonist did not produce any significant change m pressure or heart rate There was a tendency for lower heart rate nnmedlately after the antagomst m this study m the SD rats, which was slmllar m magnitude to a significant drop m heart rate observed m our previous study using a modified peptlde analogue substance P antagomst I4 Interestingly, this modest decrease m heart rate 1s also similar to the effects of the angotensm II antagomst Sarthran injected mto the nTS 3h A lower heart rate without an accompanymg change m pressure has been interpreted as a possible facllltatlon of the baroreceptor reflex,'" which would support a role for endogenous angotensm II and substance P to mhlblt the reflex control of heart rate In addition, the bldlrectlonal actions (pressor at high doses and depressor at low doses) of both substance P and angotensm II would be consistent with dose-dependent effects that might account for mhlbltlon of the reflex by either peptlde at high doses Another possible explanation for the different acute versus baroreceptor reflex effects of angotensm II 1s that angotensm II may actually mhlblt substance P release when the afferent fibers and/or mtnnslc neurons of the nTS are activated This idea 1s based on our finding that there IS no faclhtatlon of substance P release by angotensm II m the presence of high potassium m the brain slices from the medulla ') This latter pomt 1s important for interpretation of the present findings m hght of the normahzatlon of pressure under anesthesia When blood pressure decreased with the anesthetic m the TG rats, the subsequent alterations m activity of the baroreceptor reflex nerves might have contributed to the eqmvalent depressor responses observed m the two groups of rats
In these studies, we used several controls to verify the specificity of the effects of the NKI receptor antagonist First, we showed that the cardiovascular responses to nTS mJectlons of glutamate were not blocked by the NKl-selective substance P antagonist In addltlon, we ruled out a direct mteractlon of the substance P antagonist with the angotensm II receptor by showing that CP-96,345 did not compete for '2SI-angotensm II labeled receptors m the dorsal medulla Moreover, the doses of the antagonist used are below those shown previously to be specific 1R To confine the spread ofthe inJectate to the nTS, we used 30-nL mJectlons of angotensm II24 and 60-nL mjectlons of the substance P antagonist to ensure that the antagonist spread to at least the same area as the peptlde This was considered necessary, gven the overall size of the multlbarreled pipettes Thus, while we are confident that the peptlde acted within the medial nTS, we cannot rule out the posslblhty that the antagonist spread to the adjacent dmnX However, this would still provide an action of substance P within the dorsal medulla where substance P-containing nTS mterneurons may synapse on dmnX vagal motor neurons to mediate the effects of nTS angotensm II A major interest m the present work was to determine whether the responses to angotensm II were attenuated m a model of hypertension with chronic overexpresslon of tissue angotensm II levels We hypothesized that the responses would be suppressed, since we previously found that exogenously administered anglotensm peptldes m the hypothalamus of TG rats evoked smaller pressor responses and attenuated release of vasopressm and substance P lo," In addition, there are reports of alterations m substance P content39 4(1 and receptors41 m sympathetic ganglia and brain of other rat models of hypertension Therefore, we predicted that substance P release, both basal and angotensm II-induced, might be suppressed m the TG rat, leading to reduced depressor responses ehclted by angotensm II mJectlons mto the nTS In fact, we did not observe any loss of responsiveness m the TG rats with respect to either the substance P release or the cardiovascular actions. A number of observations may provide mslghts for these findings and the difference between the responses mediated by hypothalamic versus medullary pathways First, hypothalamic tissue levels of angotensm II are tenfold higher m TG rats than m SD control rats, whereas m the medulla oblongata, the elevation IS only threefold I6 Second, levels are elevated m the hypothalamic tissue of TG rats but suppressed m the medulla oblongata Ifi These tissue levels, the balance between the angotensm II and the opposmg actions of angotensm-(l-7), may play a role m the regulation of the responses In fact, another interesting parallel should be noted between the angotensm and substance P peptlde systems The substance P heptapep-Substance P Mediates Ang II Cardiovascular Effects via NKl Receptors tide, substance P-(1-7), opposes many of the actions of parent peptlde substance P42,43 and may downregulate the NKI receptor, even though it has low affinity for this receptor 44 This effect was hypothesized to occur through substance P-(I-7)-mediated prostaglandm release 44 Since angotensm-(l-7) 1s a potent stimulus for prostaglandm release m a variety of systems (see revlew45), the effects of downregulation of responses to angotensm II directly or mdlrectly through actions on the NKl receptor cannot be excluded m the hypothalamus However, the low levels of anglotensm-(l-7) m the medulla of the TG rat may account for the normal to slightly enhanced actions seen m our present study
In both the hypothalamus and the medulla of TG rats, existing data indicate that there are no differences m anglotensm II receptor density 22,46 This 1s also true m vascular smooth muscle cells or astrocytes m culture 1X,19 Even though a recent report suggests that receptor density m the aorta of TG rats may be slgmficantly lower than m SD rats,@ the magnitude of the difference observed does not appear to account for the total loss of anglotensm II actions reported m this tissue Therefore, the mechanism for the downregulation of the receptor slgnalmg and subsequent cellular responses after long-term elevations of endogenous anglotensm peptldes remains to be explained As indicated above, anglotensm II stimulated substance P release from medullary slices but tended to reduce potassmmevoked substance P release 9 We proposed that this may be a mechanism for the ability of anglotensm II to attenuate baroreflex function at sites within the nTS depending on whether the reflex pathways are activated or at a tonic level 3637 However, m the hypothalamus, the combined anglotensm II plus potassium treatment resulted m a significant increase m substance P release 9 Electrophyslologlc data4s indicate that angotensm II facilitates or inhibits nodose ganglion cells depending on the particular calcium channel or anglotensm receptor associated with the cell Thus, differences m the characteristics of neurons m the medulla and hypothalamus or then expression of different anglotensm II receptors rmght also account for the different responses m the two brain areas These potential mechanisms could be independent of the elevated tissue levels of anglotensm peptldes In summary, using a nonpeptlde, NKl-selective, substance P receptor antagonist, we provide further evidence that substance P mediates the actions of anglotensm II m the dorsal medulla oblongata The mechanism for the observed differences m responsiveness to anglotensm II between brain regions m the TG rat 1s not yet known However, it may be the result of the balance between elevated endogenous peptldes and/or specific mechanisms for desensltlza- 
